The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells

Natural killer (NK) cells and dendritic cells (DC) are thought to play critical roles in the first phases of HIV infection. In this study, we examined changes in the NK cell repertoire and functions occurring in response to early interaction with HIV-infected DC, using an autologous in vitro NK/DC coculture system. We show that NK cell interaction with HIV-1-infected autologous monocyte-derived DC (MDDC) modulates NK receptor expression. In particular, expression of the CD85j receptor on NK cells was strongly down-regulated upon coculture with HIV-1-infected MDDC. We demonstrate that CD85j+ NK cells exert potent control of HIV-1 replication in single-round and productively HIV-1-infected MDDC, whereas CD85j− NK cells induce a modest and transient decrease of HIV-1 replication. HIV-1 suppression in MDCC by CD85j+ NK cells required cell-to-cell contact and did not appear mediated by cytotoxicity or by soluble factors. HIV-1 inhibition was abolished when NK-MDDC interaction through the CD85j receptor was blocked with a recombinant CD85j molecule, whereas inhibition was only slightly counteracted by blocking HLA class I molecules, which are known CD85j ligands. After masking HLA class I molecules with specific antibodies, a fraction of HIV-1 infected MDDC was still strongly stained by a recombinant CD85j protein. These results suggest that CD85j+ NK cell inhibition of HIV-1 replication in MDDC is mainly mediated by CD85j interaction with an unknown ligand (distinct from HLA class I molecules) preferentially expressed on HIV-1-infected MDDC.

[1]  William H. Carr,et al.  Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes , 2007, The Journal of experimental medicine.

[2]  F. Mulcahy,et al.  Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. , 2007, Clinical immunology.

[3]  D. Altmann,et al.  Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease , 2007, Clinical and experimental immunology.

[4]  Amalio Telenti,et al.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.

[5]  E. Rosenberg,et al.  Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. , 2007, The Journal of infectious diseases.

[6]  D. Scott‐Algara,et al.  Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. , 2007, Blood.

[7]  Eric O Long,et al.  Activation, coactivation, and costimulation of resting human natural killer cells , 2006, Immunological reviews.

[8]  A. Moretta,et al.  Multi-directional cross-regulation of NK cell function during innate immune responses. , 2006, Transplant immunology.

[9]  L. Moretta,et al.  Effector and regulatory events during natural killer–dendritic cell interactions , 2006, Immunological reviews.

[10]  A. Cunningham,et al.  HIV interactions with dendritic cells: has our focus been too narrow? , 2006, Journal of leukocyte biology.

[11]  D. Follmann,et al.  Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection , 2006, The Journal of experimental medicine.

[12]  M. Altfeld,et al.  NK cell function in HIV-1 infection. , 2006, Current molecular medicine.

[13]  Steven Wolinsky,et al.  CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. , 2006, Virology.

[14]  L. Moretta,et al.  Early liaisons between cells of the innate immune system in inflamed peripheral tissues. , 2005, Trends in immunology.

[15]  A. Fauci,et al.  NK cells in HIV infection: paradigm for protection or targets for ambush , 2005, Nature Reviews Immunology.

[16]  Hendrik Streeck,et al.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. , 2005, Blood.

[17]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Reyburn,et al.  Genetic Variability of the Major Histocompatibility Complex Class I Homologue Encoded by Human Cytomegalovirus Leads to Differential Binding to the Inhibitory Receptor ILT2 , 2005, Journal of Virology.

[19]  T. Chun,et al.  Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. , 2004, The Journal of infectious diseases.

[20]  A. Angulo,et al.  Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. , 2004, Tissue antigens.

[21]  D. Scott‐Algara,et al.  Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users 1 , 2003, The Journal of Immunology.

[22]  M. Daucher,et al.  Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Lazzarin,et al.  Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis , 2003, AIDS.

[24]  F. Barré-Sinoussi,et al.  Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages , 2003, Journal of Virology.

[25]  T. Chun,et al.  Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. , 2003, The Journal of infectious diseases.

[26]  A. Fauci,et al.  Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. , 1998, The Journal of clinical investigation.

[27]  D. Scott‐Algara,et al.  Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long‐term culture of NK cells , 1992, Clinical and experimental immunology.

[28]  L. Moretta,et al.  NK cell activating receptors and tumor recognition in humans. , 2006, Current topics in microbiology and immunology.

[29]  C. Fortis,et al.  Natural killer cell function in HIV-1 infected patients. , 2002, Journal of Biological Regulators and Homeostatic Agents.